Cargando…

Effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants

PURPOSE: To verify the dose sparing effect of hydrogel spacer (SpaceOAR™) on rectal dosimetry for prostate brachytherapy, and to determine whether prostate and rectal dosimetry was affected by the time gap between hydrogel spacer injection and brachytherapy dosimetry. MATERIAL AND METHODS: The (103)...

Descripción completa

Detalles Bibliográficos
Autores principales: Butler, Wayne M., Kurko, Brian S., Scholl, Whitney J., Merrick, Gregory S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060959/
https://www.ncbi.nlm.nih.gov/pubmed/33897787
http://dx.doi.org/10.5114/jcb.2021.105281
_version_ 1783681467519336448
author Butler, Wayne M.
Kurko, Brian S.
Scholl, Whitney J.
Merrick, Gregory S.
author_facet Butler, Wayne M.
Kurko, Brian S.
Scholl, Whitney J.
Merrick, Gregory S.
author_sort Butler, Wayne M.
collection PubMed
description PURPOSE: To verify the dose sparing effect of hydrogel spacer (SpaceOAR™) on rectal dosimetry for prostate brachytherapy, and to determine whether prostate and rectal dosimetry was affected by the time gap between hydrogel spacer injection and brachytherapy dosimetry. MATERIAL AND METHODS: The (103)Pd brachytherapy dosimetry of 174 consecutive intermediate- and high-risk patients injected with hydrogel was compared with a dosimetry of 174 contemporaneous patients without hydrogel injections. Of the SpaceOAR™ patients, 91 had hydrogel injected upon completion of brachytherapy implant, while the remaining 83 patients had hydrogel placed prior to external beam radiation therapy (EBRT), followed 2-10 weeks later by brachytherapy. Brachytherapy implants were either planned with the prostate undistorted by any hydrogel or planned with hydrogel in place. Dosimetry of the prostate and tissues at risk was determined from CT imaging on the day of brachytherapy implant. RESULTS: SpaceOAR™ significantly reduced mean and maximum rectal doses as well as rectal wall V(50), but there was a statistically significant reduction of planning target volume (PTV) D(90) to 121.1% of the prescribed dose in hydrogel patients compared to 123.3% in the non-hydrogel patients. Rectal dosimetry was similar between patients injected with hydrogel after brachytherapy and those with spacer injected prior to EBRT. However, patients who had hydrogel placed prior to EBRT had statistically significantly higher dosimetry indices of PTV and urethra relative to those with spacer placed at the completion of brachytherapy. CONCLUSIONS: There was a significant rectal dose sparing in the cohort with hydrogel spacer compared to a reference group without spacer injection. The rectal dose sparing effect was similar in the sub-group of patients injected with hydrogel prior to EBRT and the sub-group injected with hydrogel at the conclusion of brachytherapy.
format Online
Article
Text
id pubmed-8060959
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-80609592021-04-23 Effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants Butler, Wayne M. Kurko, Brian S. Scholl, Whitney J. Merrick, Gregory S. J Contemp Brachytherapy Original Paper PURPOSE: To verify the dose sparing effect of hydrogel spacer (SpaceOAR™) on rectal dosimetry for prostate brachytherapy, and to determine whether prostate and rectal dosimetry was affected by the time gap between hydrogel spacer injection and brachytherapy dosimetry. MATERIAL AND METHODS: The (103)Pd brachytherapy dosimetry of 174 consecutive intermediate- and high-risk patients injected with hydrogel was compared with a dosimetry of 174 contemporaneous patients without hydrogel injections. Of the SpaceOAR™ patients, 91 had hydrogel injected upon completion of brachytherapy implant, while the remaining 83 patients had hydrogel placed prior to external beam radiation therapy (EBRT), followed 2-10 weeks later by brachytherapy. Brachytherapy implants were either planned with the prostate undistorted by any hydrogel or planned with hydrogel in place. Dosimetry of the prostate and tissues at risk was determined from CT imaging on the day of brachytherapy implant. RESULTS: SpaceOAR™ significantly reduced mean and maximum rectal doses as well as rectal wall V(50), but there was a statistically significant reduction of planning target volume (PTV) D(90) to 121.1% of the prescribed dose in hydrogel patients compared to 123.3% in the non-hydrogel patients. Rectal dosimetry was similar between patients injected with hydrogel after brachytherapy and those with spacer injected prior to EBRT. However, patients who had hydrogel placed prior to EBRT had statistically significantly higher dosimetry indices of PTV and urethra relative to those with spacer placed at the completion of brachytherapy. CONCLUSIONS: There was a significant rectal dose sparing in the cohort with hydrogel spacer compared to a reference group without spacer injection. The rectal dose sparing effect was similar in the sub-group of patients injected with hydrogel prior to EBRT and the sub-group injected with hydrogel at the conclusion of brachytherapy. Termedia Publishing House 2021-04-14 2021-04 /pmc/articles/PMC8060959/ /pubmed/33897787 http://dx.doi.org/10.5114/jcb.2021.105281 Text en Copyright © 2021 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Original Paper
Butler, Wayne M.
Kurko, Brian S.
Scholl, Whitney J.
Merrick, Gregory S.
Effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants
title Effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants
title_full Effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants
title_fullStr Effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants
title_full_unstemmed Effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants
title_short Effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants
title_sort effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060959/
https://www.ncbi.nlm.nih.gov/pubmed/33897787
http://dx.doi.org/10.5114/jcb.2021.105281
work_keys_str_mv AT butlerwaynem effectofthetimingofhydrogelspacerplacementonprostateandrectaldosimetryoflowdoseratebrachytherapyimplants
AT kurkobrians effectofthetimingofhydrogelspacerplacementonprostateandrectaldosimetryoflowdoseratebrachytherapyimplants
AT schollwhitneyj effectofthetimingofhydrogelspacerplacementonprostateandrectaldosimetryoflowdoseratebrachytherapyimplants
AT merrickgregorys effectofthetimingofhydrogelspacerplacementonprostateandrectaldosimetryoflowdoseratebrachytherapyimplants